ventions. A related area of research involves the adaptation and creation of technology-based interventions for the prevention of adolescent health risk behaviors. Estrada led the development and testing of eHealth Familias Unidas, an internet-based family program for the prevention of drug use among Hispanic adolescents. Currently, she is developing an individual-level mobile application for Hispanic youth for preventing drug use, sexual risk behaviors, and depression. As a researcher, her goal is to be involved in academic-community partnerships that help to develop, evaluate, and implement interventions for Hispanics in order to address the complex unmet needs among this population. Estrada received her MSEd from the University of Miami and her PhD in counseling psychology from the University of Wisconsin–Madison.

Amy Goldstein, PhD (she/her), is chief of the Prevention Research Branch in the Division of Epidemiology, Services and Prevention Research at the National Institute on Drug Abuse (NIDA). She came to NIDA from the MedStar Health Research Institute, where she was scientific director for behavioral health research. Prior to MedStar, Goldstein spent a decade at the National Institute of Mental Health (NIMH) as chief of the Preventive Intervention Research program and as associate director for prevention. During her time at NIMH, Goldstein held leadership roles in several signature projects for the Institute, including the NIMH Recovery After an Initial Schizophrenia Episode project. She also played key roles in national suicide prevention projects, including the Emergency Department Safety Assessment and Follow-up Evaluation study and the Emergency Department Screen for Teens at Risk for Suicide study. Goldstein received her bachelor’s degree in psychology from Washington University in St. Louis and her MA and PhD in clinical child psychology from Case Western Reserve University. She completed postdoctoral fellowships at the Children’s Hospital of Philadelphia and the Johns Hopkins Bloomberg School of Public Health.

Vincent Guilamo-Ramos, PhD, MPH, LSCW, RN (he/him, Planning Committee), is dean and Bessie Baker professor of the Duke University School of Nursing, and vice chancellor for nursing affairs at Duke University. He is also founding director of the Center for Latino Adolescent and Family Health at Duke University. Guilamo-Ramos is a nurse practitioner licensed in primary care and psychiatric-mental health nursing, and he is credentialed as an HIV specialist by the American Academy of HIV Medicine. Widely regarded as an expert, scholar, and leader in adolescent and young adult sexual and reproductive health promotion, Guilamo-Ramos’s research has been funded for two decades by the National Institutes of Health, Centers for Disease Control and Prevention, and Health Resources and Services Administration, as well as other federal agencies. His research focuses

on the role of families in promoting adolescent and young adult health among Latinos and in other underserved communities. Guilamo-Ramos holds an MSN from Duke University, an MPH from New York University, and a PhD from the University at Albany, State University of New York, School of Social Welfare.

Aaron Hogue, PhD (he/him, Planning Committee), is a clinical psychologist and vice president and director of family and adolescent clinical technology and science at the Partnership to End Addiction. His research interests include family involvement in youth substance use treatment and recovery services, adoption and sustainability of systemic family therapy and cognitive-behavioral therapy for youth substance use and co-occurring problems in routine care, fidelity and implementation research on evidence-based practice for youth behavioral health issues, family-based preventive interventions for youth at high risk for substance use and conduct problems, and family-centered decision-making about medication interventions for youth with substance use and mental health disorders. Hogue received his PhD in clinical psychology from Temple University.

Vinu Ilakkuvan, DrPH (she/her), is passionate about strengthening community-driven efforts to address the upstream, root drivers of health. She is founder and principal consultant of PoP Health, a public health consulting practice that partners with multisector collaboratives to transform health in their communities through policy and systems change. Ilakkuvan has extensive expertise in school mental health and adolescent misuse prevention. She is currently developing Medicaid policy recommendations to improve mental health supports and services in schools as principal investigator of a National Institute for Health Care Management funded study. Ilakkuvan is also engaging family and youth in improving mental health systems in Washington, DC and Fairfax, VA. She co-authored Addressing a Crisis: Cross-Sector Strategies to Prevent Adolescent Substance Use and Suicide and The Truth About Opioids. Ilakkuvan holds a bachelor’s degree in biomedical engineering and economics from the University of Virginia, and a master’s degree in health communications from the Harvard T.H. Chan School of Public Health. She also received a DrPH in health behavior as a Milken Scholar from the George Washington University School of Public Health, where she is currently a professorial lecturer.

Margaret Kuklinski, PhD (she/her, Planning Committee), is associate professor and director of the Social Development Research Group (SDRG) at the University of Washington School of Social Work. As SDRG director, she oversees multidisciplinary staff engaged in promoting healthy development and preventing problem behaviors in young people through rigorous

prevention science and intervention. Her work aims to promote positive developmental outcomes by demonstrating the long-term impact of effective family-focused and community-based preventive interventions; partnering with communities, agencies, and services systems to implement and scale them; and building policy support for preventive interventions by demonstrating their benefits and costs. Kuklinski is an elected board member of the Society for Prevention Research and is a member of the National Academy of Sciences’ Collaborative on Healthy Parenting in Primary Care with the Forum for Children’s Well-Being. She received a PhD in psychology from the University of California, Berkeley.

John Lowe, RN, PhD (he/him), is Joseph Blades centennial memorial professor at the University of Texas at Austin School of Nursing. He is a Cherokee Native American tribal member, and has Creek and Lenape Native American tribal heritage. Lowe developed the first Indigenous Nursing Research Center. He currently serves as a member of the advisory council to the National Institute of Nursing Research. With Roxanne Struthers (Ojibwe), he co-authored A Conceptual Framework for Nursing in Native American Culture. He is an alumnus of the Minority Fellowship Program (MFP) at the American Nurses Association, and has served as chair of the National Advisory Council to the MFP. Lowe developed the first manualized Talking Circle intervention for reducing substance use and other risk behaviors among Native American and Indigenous youth globally. These studies and other health programs are guided by the Lowe’s Native-Reliance theoretical framework and model. The Talking Circle intervention has been recognized by the U.S. Department of Justice’s Office of Justice Programs as a “Promising Evidence-Based Program”; it has also been featured as one of the American Academy of Nursing’s “Edge Runners,” and most recently featured in the National Academy of Medicine report The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity. Lowe was the first Native American man to earn a PhD in nursing and to be inducted as a fellow in the American Academy of Nursing.

Pamela A. Matson, PhD, MPH (she/her), is assistant professor of pediatrics and director of research in the Division of Adolescent and Young Adult Medicine at the Johns Hopkins University School of Medicine with an appointment in the Department of Population, Family, and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health. Matson studies the mechanisms by which social determinants produce health disparities in adolescent substance use, teen dating violence, and sexually transmitted infections. As an epidemiologist, she has led several federally funded cohort studies that have collected intensive longitudinal data from youth. She has published widely on the intersection of social and commu-

nity contexts on adverse outcomes for youth. Her current work focuses on research and addiction medicine training to incorporate a family systems approach to improve prevention and early intervention on adolescent substance use in primary care settings. Matson has provided expert consultation on recommended actions for medical providers for the prevention of and early identification of substance use among adolescents and young adults. She has written and presented extensively on universal screening for family substance use in pediatrics primary care settings. Matson completed her MPH in epidemiology of microbial diseases from Yale University School of Public Health and her doctoral training in infectious disease epidemiology from the Johns Hopkins Bloomberg School of Public Health.

Erin McKnight, MD, MPH (she/her, Planning Committee), is a member of the Division of Adolescent Medicine at Nationwide Children’s Hospital (NCH) and assistant professor of clinical pediatrics at The Ohio State University College of Medicine. She is currently medical director of the Medication-Assisted Treatment for Addiction Program at NCH, providing care for youth with substance use disorders. McKnight is co-chair of the Opioid Safety Task Force at NCH, utilizing quality improvement methods to decrease opioid prescribing and improve opioid safety, and creating a multitude of educational tools for providers, patients, families, and the community. In addition to quality-improvement efforts, her research interests include the epidemiological investigation of opioid misuse, developing models to better predict opioid misuse at the local level for improved allocation of funds. McKnight received her MD from Northeast Ohio Medical University College of Medicine and her MPH from The Ohio State University.

Brenda Miller, PhD (she/her), is senior scientist at Pacific Institute for Research and Education. She and her colleagues’ research focuses on evidence-based interventions (EBIs) for addressing adolescent alcohol and other drug (AOD) use and risky sexual behaviors by engaging both the parent and adolescent in interventions. Most recently, this research involved the delivery of an online, interactive intervention to parents and older teens (16–17 years of age) on parent-teen communications, strategies, and skills for reducing the risks associated with teen AOD use and romantic relationships. This intervention significantly reduced risks, and the team is planning to study strategies for implementation in community settings. Previously, Miller and colleagues implemented an EBI for families in Thailand and made successful adaptations for this cultural context. Earlier in her career, Miller focused on issues of child abuse, childhood sexual abuse, and intimate partner violence, and the relationship of these experiences to women’s AOD use. In addition to her focus on family-based interventions for adolescents, she and

her colleagues have an extensive portfolio of research on young adult AOD use in nightclubs, including the development of a group-based intervention for reducing risks related to AOD use, physical, and sexual aggression for young adults in these settings. Miller earned a BS in social welfare from the University of Illinois Urbana-Champaign, as well as a MS and PhD in criminal justice from the University at Albany, State University of New York.

Christopher O’Connell, MBA (he/him), is a passionate supporter of community-driven substance misuse prevention public health services. He joined the Substance Abuse and Mental Health Services Administration (SAMHSA) in 2018, and currently serves as deputy director in the Center for Substance Abuse Prevention, where he supports a team overseeing prevention grants, technical assistance, public engagement campaigns, and the Federal Drug-Free Workplace program. Prior to joining SAMHSA, O’Connell spent 13 years supporting the U.S. President’s Emergency Plan for AIDS Relief, including two tours in Africa, as well as seven years supporting programs in Latin America, Eastern Europe, and Southeast Asia at the Office of the Global AIDS Coordinator. He currently serves on the Alexandria Commission on HIV/AIDS. O’Connell holds an MBA in healthcare management.

Terrinieka Powell, PhD, MA (she/her, Planning Committee), is vice chair of inclusion, diversity, anti-racism, and equity, and associate professor at Johns Hopkins Bloomberg School of Public Health. She is also director of The B Lab, which is focused on the supporting the needs of Black adolescents and young adults (10–24 years old) living in urban communities across the United States. Powell is a trained community psychologist with expertise in adolescent health, community-engaged research, qualitative methodologies, and implementation science. Partnerships with churches, schools, libraries, families, and community-based organizations are a cornerstone of her research. Powell has collaborated with institutions across several states to promote adolescent well-being as well as to prevent teen pregnancy, HIV, and substance use among adolescents of color. She received her PhD from DePaul University.

Linda Richter, PhD (she/her), is vice president of prevention research and analysis at the Partnership to End Addiction, where she has been conducting research on the nature, scope, predictors, and consequences of all forms of substance use and addiction, especially among young people. She leverages this research to help raise awareness among parents, educators, health professionals, and policy makers about best practices in substance use prevention and addiction care. Richter serves on substance use advisory panels and regularly presents at local and national professional

conferences, as well as to schools and communities, about youth substance use. She received her doctorate in psychology from the University of Maryland.

Daniel S. Shaw, PhD (he/him), is director of the Center for Parents and Children and the Pitt Parents and Children Laboratory, and is distinguished professor in the Department of Psychology at the University of Pittsburgh, with joint appointments in the schools of medicine and education, the Clinical and Translational Science Institute, and the Center for Social and Urban Research. His primary interest is studying the development and prevention of early problem behavior among at-risk children. He currently leads or codirects four National Institutes of Health (NIH) funded longitudinal studies investigating the early antecedents and prevention of childhood conduct problems and substance use, and directs a large-scale implementation study entitled The Pittsburgh Study. Additionally, Shaw directs multiple implementation projects in various community agencies serving low-income families (e.g., pediatrics; Early Head Start; Family Centers; Early Intervention). Shaw is associate editor of the journal Development and Psychopathology and has served on several editorial boards of journals (e.g., Child Development, Developmental Psychology). He has been a member or chair of several expert panels convened by NIH, including recently serving as chair of NIH’s Psychosocial Development, Risk and Prevention Study Section. He received his PhD in child clinical and developmental psychology from the University of Virginia.

Justin D. Smith, PhD (he/him), is associate professor in the Department of Population Health Sciences in the Spencer Fox Eccles School of Medicine at the University of Utah. He directs the Dissemination and Implementation Science Core of the Utah Clinical and Translational Sciences Institute and codirects the Health Behavior Intervention, Implementation, and Translation Core of the University of Utah Diabetes and Metabolism Research Center. He is also co-director of the Community Intervention to Reduce Cardiovascular Disease in Chicago, funded by the National Heart, Lung, and Blood Institute, which aims to eliminate health disparities in hypertension for African Americans on Chicago’s South Side. As an implementation scientist and clinical psychologist, Smith leads the implementation science activities of projects focused on interventions for obesity, hypertension, mental health, HIV prevention and treatment, cancer prevention and survivorship, and other conditions. He is on the training faculty of multiple National Institutes of Health funded implementation science programs for cancer, HIV, mental health, and substance use. His research has also been supported by the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the Health Resources and Services

Administration, the U.S. Department of Agriculture, and foundations. He serves on a number of national committees and advisory panels on implementation science and is currently associate editor of the journals Prevention Science and Families, Systems, and Health. He completed his PhD in clinical psychology at the University of Tennessee, Knoxville, and postdoctoral training at the University of Oregon and Arizona State University.

Kimá Joy Taylor, MD, MPH (she/her), is founder of Anka Consulting LLC, a health care consulting company, and is an Urban Institute nonresident fellow. Her areas of expertise include identifying policy, programming, and financing levels to improve health and racial equity, integrate behavioral health, primary care, and social services, and support the system change necessary to embrace cost-effective, holistic health care solutions. Taylor collaborates with Urban Institute researchers on a number of topics, including analyses of racial disparities in screening and treatment practices for parents with substance use disorder, management of neonatal abstinence syndrome, and behavioral health concerns among adolescents and young adults. Prior to Anka, she served as the national drug addiction treatment and harm reduction program director at the Open Society Foundations (OSF), overseeing grant making to redefine and expand access to a full continuum of community, justice-based, culturally effective substance use services for all, and to replace current discriminatory justice system responses to substance use. Prior to OSF, Taylor served as deputy commissioner for the Baltimore City Health Department, as health and social policy legislative assistant for Senator Paul Sarbanes, and as a practicing pediatrician in a federally qualified health center in Washington, DC. A board-certified pediatrician, she is a graduate of Brown University, Brown University School of Medicine, and the Georgetown University residency program in pediatrics. In 2002, Taylor was awarded a Commonwealth Foundation fellowship in minority health policy at Harvard University.

Breda Velasquez, MD (she/her), is a psychiatrist who works with children and adolescents at Kaiser Permanente San Diego, where she is assistant chief of psychiatry. Velasquez is also a faculty member of the Kaiser San Diego family medicine residency program and is chair of the Physician Well-Being Committee. Previously, she worked as the clinical lead for the Care Management Institute, developing assessment and treatment guidelines for attention deficit hyperactivity disorder and autism spectrum disorder. Velasquez has more than 30 years of experience in medicine, and completed her adult psychiatry residency at the University of California, Los Angeles/San Fernando Valley, and her child and adolescent psychiatry fellowship at Cedars-Sinai Medical Center in Los Angeles. She received her medical degree from the University of Belgrade Faculty of Medicine.